Antibiotic Stewardship: The Current State in Tennessee Jeff - - PowerPoint PPT Presentation

antibiotic stewardship
SMART_READER_LITE
LIVE PREVIEW

Antibiotic Stewardship: The Current State in Tennessee Jeff - - PowerPoint PPT Presentation

Antibiotic Stewardship: The Current State in Tennessee Jeff Binkley, PharmD, BCNSP, FASHP Co-Chair, Tennessee Pharmacists Coalition Administrative Director of Pharmacy Maury Regional Medical Center Tennessee Pharmacist Coalition Vision Reduce


slide-1
SLIDE 1
slide-2
SLIDE 2

Antibiotic Stewardship: The Current State in Tennessee

Jeff Binkley, PharmD, BCNSP, FASHP Co-Chair, Tennessee Pharmacists Coalition Administrative Director of Pharmacy Maury Regional Medical Center

slide-3
SLIDE 3

Tennessee Pharmacist Coalition Vision

Reduce harm and preventable adverse drug events through directed inquiry into current pharmacy practices, identify medication safety-gaps, and make recommendations for best practice across Tennessee.

slide-4
SLIDE 4

Tennessee Pharmacist Coalition Goals

  • Inspire pharmacist’s engagement
  • Align partners & agencies efforts on medication

safety

  • Identify performance measures
  • Collaborate to spread best practices
  • Provide education and resources for pharmacists and

schools of pharmacy

slide-5
SLIDE 5

Statewide Collaborative Partners

slide-6
SLIDE 6

Recognition

  • July 2014 ASHP Journal article
  • CMS/Partnership for Patients National webinars
  • Medication Safety Affinity Group webinars
  • CMS Community of Practice website and

electronic newsletters

  • Endorsed by THA Board of Directors
slide-7
SLIDE 7
  • Changing the culture
  • Identified measures for ADE reporting
  • Target pharmacy directors/ medication

safety officers

  • Assist hospitals with data collection

processes

Strategies for Improvement

slide-8
SLIDE 8
  • Formation of the Tennessee Pharmacist Coalition
  • Work groups with targeted focus areas
  • Data review for successes and improvement
  • pportunities
  • Educational webinars
  • Presentations at statewide and regional meetings
  • Website to share deliverables and resources
  • Provide updates to THA Board of Directors for

consideration

Strategies for Sustainability

slide-9
SLIDE 9

THA Board of Directors Endorsed Antibiotic Stewardship Recommendations

  • Demonstrate commitment to antibiotic

stewardship via a written statement of support for dedicated pharmacy, clinician, and IT staff time for antibiotic stewardship activities

  • All hospitals commit to reporting to the National

Healthcare Safety Network antimicrobial use and resistance modules within specified timeframes

  • All hospitals commit to a policy requiring

documentation of indications for antibiotic therapy

slide-10
SLIDE 10

THA Board of Directors Endorsed Antibiotic Stewardship Recommendations

  • All hospitals commit to implementing a policy

requiring an “antibiotic review” after 48-72 hours to allow for appropriate review.

  • Participation by hospitals in an antibiotic

stewardship collaborative to encourage best practice, sharing, and education.

slide-11
SLIDE 11

Antibiotic Stewardship NHSN Survey Questions

Number of Participating Hospitals: 2014: 102 2015: 100

slide-12
SLIDE 12

This information is prepared and protected in accordance with the Tennessee Patient Safety and Quality Improvement Act of 2011. T.C.A. 68-11-272.

NHSN Hospital Survey Question #11

slide-13
SLIDE 13

This information is prepared and protected in accordance with the Tennessee Patient Safety and Quality Improvement Act of 2011. T.C.A. 68-11-272.

NHSN Hospital Survey Question #12

slide-14
SLIDE 14

This information is prepared and protected in accordance with the Tennessee Patient Safety and Quality Improvement Act of 2011. T.C.A. 68-11-272.

NHSN Hospital Survey Question #23

slide-15
SLIDE 15

This information is prepared and protected in accordance with the Tennessee Patient Safety and Quality Improvement Act of 2011. T.C.A. 68-11-272.

NHSN Hospital Survey Question #24

slide-16
SLIDE 16

This information is prepared and protected in accordance with the Tennessee Patient Safety and Quality Improvement Act of 2011. T.C.A. 68-11-272.

NHSN Hospital Survey Question #25

slide-17
SLIDE 17

This information is prepared and protected in accordance with the Tennessee Patient Safety and Quality Improvement Act of 2011. T.C.A. 68-11-272.

NHSN Hospital Survey Question #26

slide-18
SLIDE 18

This information is prepared and protected in accordance with the Tennessee Patient Safety and Quality Improvement Act of 2011. T.C.A. 68-11-272.

NHSN Hospital Survey Question #27

slide-19
SLIDE 19

This information is prepared and protected in accordance with the Tennessee Patient Safety and Quality Improvement Act of 2011. T.C.A. 68-11-272.

NHSN Hospital Survey Question #28

slide-20
SLIDE 20

This information is prepared and protected in accordance with the Tennessee Patient Safety and Quality Improvement Act of 2011. T.C.A. 68-11-272.

NHSN Hospital Survey Question #29

slide-21
SLIDE 21

This information is prepared and protected in accordance with the Tennessee Patient Safety and Quality Improvement Act of 2011. T.C.A. 68-11-272.

NHSN Hospital Survey Question #30

slide-22
SLIDE 22

This information is prepared and protected in accordance with the Tennessee Patient Safety and Quality Improvement Act of 2011. T.C.A. 68-11-272.

NHSN Hospital Survey Question #31

slide-23
SLIDE 23

This information is prepared and protected in accordance with the Tennessee Patient Safety and Quality Improvement Act of 2011. T.C.A. 68-11-272.

NHSN Hospital Survey Question #32

slide-24
SLIDE 24

NHSN Hospital Survey Question #32

This information is prepared and protected in accordance with the Tennessee Patient Safety and Quality Improvement Act of 2011. T.C.A. 68-11-272.

slide-25
SLIDE 25

This information is prepared and protected in accordance with the Tennessee Patient Safety and Quality Improvement Act of 2011. T.C.A. 68-11-272.

NHSN Hospital Survey Question #32

slide-26
SLIDE 26

This information is prepared and protected in accordance with the Tennessee Patient Safety and Quality Improvement Act of 2011. T.C.A. 68-11-272.

NHSN Hospital Survey Question #32

slide-27
SLIDE 27

This information is prepared and protected in accordance with the Tennessee Patient Safety and Quality Improvement Act of 2011. T.C.A. 68-11-272.

NHSN Hospital Survey Question #33

slide-28
SLIDE 28

This information is prepared and protected in accordance with the Tennessee Patient Safety and Quality Improvement Act of 2011. T.C.A. 68-11-272.

NHSN Hospital Survey Question #34

slide-29
SLIDE 29
slide-30
SLIDE 30

Antibiotic Stewardship Survey

Fall, 2016 Preparation for Medication Safety Summit on Antibiotic Stewardship

slide-31
SLIDE 31
slide-32
SLIDE 32

19 18 17 8 7 6 5 1 2 4 6 8 10 12 14 16 18 20 1

Top 5 Antibiotics by Use

Rocephin Vancomycin Levofloxin & Zosyn Cefazolin Azithromycin Meropenem Cipro Avelox, Bactrim DS, Clindamycin, Gentamicin, Macrobid & Metronidazole

slide-33
SLIDE 33

12 10 9 7 6 5 4 3 2 1 2 4 6 8 10 12 14 1

Top 5 Antibiotics by Cost

Daptomycin Vancomycin Zosyn Meropenem & Teflaro Zyvox Ertapenem & Tygacil Azatam & Rocephin Azithromycin & Doxycycline Avycaz, Bicillin LA, Cefepime & Levofloxin Amikacin, Amphotericin B, Avelox, Cefazolin, Cefoxin, Cleocin, Clindamycin, Nafcillin, PCN G, Primaxin, Rifampin, Zerbaxa

slide-34
SLIDE 34

21 17 14 12 10 9 6 4 1 5 10 15 20 25 1

Top 5 Organisms Encountered

  • E. coli

Pseudomonas Enterococcus Klebsiella & Staph. aureus MRSA Proteus mirabilis MSSA Coag neg. Staph Candida Albicans, E.Cloaccae & Streptococcus alalactiae

slide-35
SLIDE 35
slide-36
SLIDE 36
slide-37
SLIDE 37
slide-38
SLIDE 38

Antibiotic Stewardship: New Standards

slide-39
SLIDE 39
slide-40
SLIDE 40

Antibiotic Stewardship: Resources